Skip to main content
Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News FAQ
On This Report

Brain Mapping Instruments Market Size & Growth Forecast 2027–2036, By Segments (Product), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 13241| Published Date: Aug-2026| Format: PDF, Excel
Market Outlook

Market Size and Growth Outlook

Brain Mapping Instruments Market size was valued at USD 2.3 billion in 2026 and is anticipated to grow at a 5.99% CAGR from 2027 to 2036, crossing USD 4.12 billion by 2036. The industry revenue for 2027 is estimated at USD 2.42 billion.

Base Year Value (2026)
USD 2.3 billion
CAGR (2027-2036)
5.99%
Forecast Year Value (2036)
USD 4.12 billion
Historical Data Period
2022-2026
Largest Region
North America
Forecast Period
2027-2036

Get more details on this report

Request Free Sample Report
Snapshot

Brain Mapping Instruments Market Intelligence Snapshot

Regional Market Dynamics

  • North America held a 32.75% market share in 2026, supported by advanced neurodiagnostic infrastructure, strong neuroscience research, and consistent adoption across hospitals, research centers, and surgical planning applications.
  • Asia Pacific is projected to expand at a 6.67% CAGR, fueled by growing neurological care, increased investment in research capabilities, and wider adoption of advanced brain monitoring and imaging technologies.

Segment Momentum

  • CAT accounted for 22.14% of the market in 2026, supported by its routine use in neurological imaging, rapid structural assessment, and widespread availability across hospitals and diagnostic facilities.
  • EEG is the fastest-growing segment because demand is increasing for real-time functional brain monitoring, supporting continuous neurological assessment and applications requiring direct measurement of brain activity.

Market Expansion Drivers

  • Rising prevalence of neurological disorders increasing demand for advanced diagnostics.
  • Expansion of hospital neurodiagnostic infrastructure boosting equipment adoption.
  • Integration of AI-based neuroimaging enhancing diagnostic precision and efficiency.

Leading Market Participants

  • Prominent players in the brain mapping instruments market include Medtronic plc (Ireland), Siemens Healthineers AG (Germany), Koninklijke Philips N.V. (Netherlands), GE HealthCare Technologies Inc. (United States), Nihon Kohden Corporation (Japan), Natus Medical Incorporated (United States), Brain Products GmbH (Germany), Compumedics Limited (Australia), BrainScope Company, Inc. (United States), Advanced Brain Monitoring, Inc. (United States).

Forecast Snapshot

Global Market Forecast Snapshot

Market Outlook

  • 2026 Market Size: USD 2.3 billion
  • 2027 Estimated Market Size: USD 2.42 billion.
  • Projected Market Size: USD 4.12 billion by 2036
  • Growth Forecast: 5.99% CAGR (2027-2036)

Regional and Segment Outlook

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Computed Axial Tomography (CAT) (Product)
  • Emerging Opportunity Segment: Electroencephalography (EEG) (Product)
Market Dynamics

Market Growth Drivers and Industry Trends

Rising prevalence of neurological disorders increasing demand for advanced diagnostics

The growing burden of neurological disorders is driving the brain mapping instruments market by increasing the need for detailed assessment of brain structure, function, and neural activity. Conditions involving cognitive impairment, epilepsy, neurodegenerative changes, and other neurological abnormalities often require sophisticated diagnostic evaluation to identify affected regions and support treatment planning. Brain mapping technologies can provide clinicians and researchers with more comprehensive information than conventional assessments alone, helping characterize functional and anatomical changes associated with neurological conditions. As neurological care becomes increasingly dependent on precise localization and individualized clinical evaluation, hospitals and specialized centers are placing greater emphasis on diagnostic technologies capable of supporting complex brain assessments.

Expansion of hospital neurodiagnostic infrastructure boosting equipment adoption

Investment in hospital neurodiagnostic infrastructure is expanding opportunities for the brain mapping instruments market as healthcare providers develop more specialized capabilities for neurological evaluation and treatment planning. Modern neurology departments increasingly require integrated diagnostic environments that can support electrophysiological monitoring, functional assessment, imaging-based analysis, and preoperative evaluation. The establishment and modernization of dedicated neurodiagnostic units can therefore create demand for advanced instruments that improve clinicians' ability to visualize and interpret brain activity. Increased availability of specialized equipment within hospitals also facilitates earlier assessment, multidisciplinary collaboration, and more consistent monitoring of patients undergoing neurological care.

Integration of AI-based neuroimaging enhancing diagnostic precision and efficiency

Integration of artificial intelligence into neuroimaging workflows is enhancing the capabilities of the brain mapping instruments market by enabling faster processing and more sophisticated interpretation of complex neurological data. AI-based systems can assist with identifying subtle patterns, segmenting anatomical structures, analyzing functional information, and highlighting abnormalities that may require closer clinical attention. These capabilities can reduce the burden associated with manual image interpretation while supporting more standardized analysis across large volumes of diagnostic information. As hospitals and research institutions increasingly combine advanced imaging hardware with computational tools, the ability to generate actionable insights from brain data is becoming an important consideration in the adoption of next-generation mapping technologies.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Rising prevalence of neurological disorders increasing demand for advanced diagnostics 2.00% High North America, Europe High Near Term
Expansion of hospital neurodiagnostic infrastructure boosting equipment adoption 1.70% High Global Medium Mid Term
Integration of AI-based neuroimaging enhancing diagnostic precision and efficiency 1.80% Moderate North America, Europe Medium Mid Term
Custom Research

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
Regional Forecast

Regional Demand Dynamics

Brain Mapping Instruments Market
Largest Region
North America
32.75% Market Share in 2026

North America (Largest Region)

In the brain mapping instruments market, North America accounted for the largest share at 32.75% in 2026, supported by advanced neuroscience research infrastructure, sophisticated neurosurgical capabilities, and strong adoption of technologies used for functional and structural brain assessment. Extensive research activity in neurological disorders and continued development of precision surgical approaches are creating demand for advanced mapping instruments. The presence of specialized medical centers and increasing integration of imaging, electrophysiological, and navigation technologies into neurological procedures further reinforces the region’s market position.

Asia Pacific (Fastest-Growing Region)

Asia Pacific is the fastest-growing region, supported by expanding neurological care infrastructure, increasing investment in medical research, and improving access to advanced diagnostic and surgical technologies. Rising awareness of neurological disorders is encouraging healthcare providers to strengthen capabilities for brain assessment and intervention. The modernization of hospitals, development of specialized treatment centers, and growing adoption of technology-assisted neurosurgical procedures are creating additional opportunities for brain mapping instruments across the region.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
Country Insights

Key Country Insights

Germany 🇩🇪

Precision Research Focus

Germany emphasizes brain mapping instruments that improve research accuracy and clinical workflow across neurological disorders. Investments in academic neuroscience programs and medical device engineering encourage demand for high-performance imaging and analysis platforms.

France 🇫🇷

Translational Research Support

France promotes brain mapping instruments that bridge academic neuroscience and clinical practice. Research hospitals focus on technologies that improve understanding of neurological disorders while supporting collaborative studies and advanced patient assessment.

Italy 🇮🇹

Specialized Clinical Adoption

Italy is expanding the application of brain mapping instruments in specialized neurological centers and university hospitals. Demand is centered on solutions that enhance surgical planning, epilepsy evaluation, and multidisciplinary neuroscience research activities.

Japan 🇯🇵

Neurotechnology Integration

Japan is expanding the use of brain mapping instruments through integration with robotics, neurorehabilitation, and cognitive research initiatives. Healthcare providers seek compact, reliable systems that support detailed functional brain analysis in both research and clinical environments.

South Korea 🇰🇷

Digital Neuroscience Expansion

South Korea is strengthening demand for brain mapping instruments through digital healthcare initiatives and neuroscience research programs. Local institutions increasingly value systems that combine advanced imaging, AI-assisted analysis, and efficient clinical data management.

United States 🇺🇸

Clinical Innovation Hub

The U.S. continues to prioritize advanced brain mapping instruments for neuroscience research, precision diagnostics, and neurosurgical planning. Collaboration between hospitals, research institutions, and technology developers supports adoption of multimodal imaging and data integration capabilities.

Segment Analysis

Segment Leadership and Growth Trends

Brain Mapping Instruments Market Share (%), by Product, 2026

Computed Axial Tomography (CAT)
Functional MRI (fMRI)
Positron Emission Tomography (PET)
Electroencephalography (EEG)
Functional Near-Infrared Spectroscopy (fNIRS)
Others

Go beyond the chart, access full insights & data tables

Request Free Sample Report

Product Segment Analysis: Computed Axial Tomography (CAT) (Largest Segment) vs Electroencephalography (EEG) (Fastest-Growing Segment)

Computed axial tomography (CAT) held the largest share of the brain mapping instruments market in 2026, accounting for 22.14%. Its strong market position is supported by the ability to generate detailed structural images of the brain and assist clinicians in identifying abnormalities relevant to neurological assessment and treatment planning. CAT-based imaging is widely integrated into diagnostic workflows because of its established clinical utility and ability to support rapid evaluation of neurological conditions. Continued demand for advanced brain imaging, particularly in settings requiring dependable structural visualization and diagnostic support, reinforces the segment's importance within the product landscape.

Electroencephalography (EEG) is gaining traction as demand increases for technologies capable of capturing and analyzing brain electrical activity. EEG supports neurological assessment by providing functional information that complements structural imaging, making it valuable across applications involving seizure activity, brain disorders, and neurological monitoring. Advances in digital signal processing and the increasing integration of computerized analysis are improving the usability and interpretation of EEG data. Greater emphasis on functional brain assessment and continuous neurological monitoring is creating additional opportunities for EEG-based instruments, supporting its faster expansion within the market.

Segment Sub-Segment Largest Segment Fastest Growing
Product Computed Axial Tomography (CAT), Positron Emission Tomography (PET), Electroencephalography (EEG), Functional MRI (fMRI), Functional Near-Infrared Spectroscopy (fNIRS), Others Computed Axial Tomography (CAT) Electroencephalography (EEG)
Read our Research Approach →
Competitive Landscape

Competitive Landscape and Market Positioning

Leading companies in the brain mapping instruments market:

1. Medtronic plc (Ireland)

2. Siemens Healthineers AG (Germany)

3. Koninklijke Philips N.V. (Netherlands)

4. GE HealthCare Technologies Inc. (United States)

5. Nihon Kohden Corporation (Japan)

6. Natus Medical Incorporated (United States)

7. Brain Products GmbH (Germany)

8. Compumedics Limited (Australia)

9. BrainScope Company Inc. (United States)

10. Advanced Brain Monitoring Inc. (United States)

The brain mapping instruments market is advancing with growing integration of high-resolution imaging and computational neuroscience tools. New instruments are improving diagnostic precision in neurological assessments. Research initiatives are enhancing imaging clarity and data interpretation, while collaborative development is strengthening clinical neuroscience applications.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
Medtronic plc (Ireland)
Siemens Healthineers AG (Germany)
Koninklijke Philips N.V. (Netherlands)
GE HealthCare Technologies Inc. (United States)
Nihon Kohden Corporation (Japan)
Natus Medical Incorporated (United States)
Brain Products GmbH (Germany)
Compumedics Limited (Australia)
BrainScope Company Inc. (United States)
Advanced Brain Monitoring Inc. (United States).
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
Brain Products GmbH Jul-24 Brain Products released BrainVision Analyzer 2.3.0.8301 software for EEG and ERP data processing and analysis. The platform supports multiple data formats and MATLAB integration, enhancing neuroscientific research workflows and strengthening analytical capabilities for brain mapping and electrophysiological data interpretation.
Medtronic plc Jan-24 Medtronic received FDA approval for its Percept RC Deep Brain Stimulation system, expanding its neuromodulation portfolio with a rechargeable neurostimulator. The system integrates BrainSense technology and complements existing Percept PC and SenSight directional lead offerings, strengthening Medtronic’s position in advanced brain mapping and neuromodulation solutions.
Report Customization

Customize Your Report

Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.

1 Custom Segments 2 Custom TOC 3 Related Reports

Brain Mapping Instruments Market — Custom Segments

Segment Sub-Segment
End User Hospitals & Clinics, Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Specialty Neurology Centers
Application Neuroscience Research, Neurological Disease Diagnosis, Surgical Planning & Guidance, Neurorehabilitation, Drug Development
Purchase Type New Equipment Purchases, Replacement & Upgrades, Equipment Leasing & Rental

Brain Mapping Instruments Market — Custom TOC

Custom Chapter Custom Details
Neuroscience Research Funding and Investment Landscape
  • Research Funding Priorities Across Neuroscience
  • Public and Institutional Investment Trends
  • Technology Investment Drivers and Research Infrastructure Needs
  • Funding Gaps and Emerging Research Priorities
  • High-Potential Investment Areas
Clinical Adoption Across Neurology and Neurosurgery Centers
  • Brain Mapping Adoption Across Clinical Settings
  • Neurology and Neurosurgery Use Cases
  • Institutional Readiness and Infrastructure Requirements
  • Clinical Adoption Barriers
  • Priority Clinical Opportunity Areas
Precision Medicine and Functional Neuroscience Opportunities
  • Brain Mapping Applications in Precision Neuroscience
  • Functional Brain Assessment and Treatment Planning
  • Integration with Personalized Clinical Approaches
  • Emerging Research-to-Clinical Translation Opportunities
  • High-Potential Application Areas

Need a different cut of the data?

Request Custom Research
Frequently Asked Questions

How much is the brain mapping instruments market worth?

The market valuation of the brain mapping instruments is USD 2.42 billion in 2027.

What is the expected industry size of brain mapping instruments by 2036?

Brain Mapping Instruments Market size was valued at USD 2.3 billion in 2026 and is anticipated to grow at a 5.99% CAGR from 2027 to 2036, crossing USD 4.12 billion by 2036.

How is the rising burden of neurological disorders influencing demand for brain mapping technologies?

Increasing neurological cases are driving demand for high-precision diagnostic tools that enable earlier detection and accurate localization of brain abnormalities for treatment planning, surgical guidance, and patient monitoring.

Why are hospital infrastructure expansion and AI integration key drivers of brain mapping instrument adoption?

Expanding neurodiagnostic departments are increasing procurement of advanced systems, while AI-enabled imaging improves diagnostic speed and accuracy, making workflows more efficient and strengthening reliance on integrated brain mapping platforms.

Why does computed axial tomography (CAT) lead the brain mapping instruments market?

CAT accounted for 22.14% of the market in 2026, supported by its routine use in neurological imaging, rapid structural assessment, and widespread availability across hospitals and diagnostic facilities.

Why is electroencephalography (EEG) the fastest-growing segment in the brain mapping instruments market?

EEG is the fastest-growing segment because demand is increasing for real-time functional brain monitoring, supporting continuous neurological assessment and applications requiring direct measurement of brain activity.

Why is North America the leading market for brain mapping instruments?

North America held a 32.75% market share in 2026, supported by advanced neurodiagnostic infrastructure, strong neuroscience research, and consistent adoption across hospitals, research centers, and surgical planning applications.

What is driving brain mapping instruments market growth in Asia Pacific?

Asia Pacific is projected to expand at a 6.67% CAGR, fueled by growing neurological care, increased investment in research capabilities, and wider adoption of advanced brain monitoring and imaging technologies.

What are the key competitors in the brain mapping instruments landscape?

Prominent players in the brain mapping instruments market include Medtronic plc (Ireland), Siemens Healthineers AG (Germany), Koninklijke Philips N.V. (Netherlands), GE HealthCare Technologies Inc. (United States), Nihon Kohden Corporation (Japan), Natus Medical Incorporated (United States), Brain Products GmbH (Germany), Compumedics Limited (Australia), BrainScope Company, Inc. (United States), Advanced Brain Monitoring, Inc. (United States).
Testimonials

Our Clients

"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."

Project Manager
Siemens Healthcare

"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."

Research and Development (R&D) Manager
GC Biopharma

"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."

Quality Assurance Manager
Medtronic
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →